Uncategorized, Health and Disease

Brain Games for Seniors

Brain Games for Seniors

 

Games for People with Alzheimer's Disease and Dementia

Many doctors encourage seniors to use brain fitness games as a means to help deal with dementia, Alzheimer’s and other cognitive diseases, says SeniorLiving.org.

 

While research remains inconclusive, there appears to be a correlation between brain games and brain health.

The website says brain games that may help seniors include:

  • Memory games, such as Match and Simon.
  • Word games, such as word searches and Scrabble.
  • Electronic games, such as Jeopardy, Wheel of Fortune and Family Feud.
  • Board games, such as Chess and Checkers.
  • Interactive Wii and X-Box games.
  • Trivia games, such as Trivial Pursuit.

 

If you need help determining which supplements you should take to prevent dementia, please contact us.

Remember, We are in this together!

Health and Wellness Associates
EHS Telehealth

WordPress:  https://healthandwellnessassociates.co/

Health and Disease, Uncategorized

Your Noisy Knees May Be Trying to Tell You Something

Your Noisy Knees May Be Trying to Tell You Something

News Picture: Your Noisy Knees May Be Trying to Tell You Something

Ever hear your joints clicking, creaking or crunching? Now, researchers say a new technique that listens closely to knees may help doctors diagnose and monitor osteoarthritis.

In the new study, researchers attached small microphones to participants’ knees, which allowed them to listen for high-frequency sounds as the person repeatedly stood up and sat down again.

Computer analysis of the sounds then provided information about the health of the knee, the study authors explained.

This study is the first to assess this technique in a large number of people with knee osteoarthritis. It was found to distinguish between healthy knees and those afflicted by this “wear-and-tear” form of arthritis.

The findings move the technique a step closer to use by doctors and in research, according to the report published Oct. 16 in the journal PLOS ONE.

“This work is very exciting because it involves scientists and clinicians working together as a team to develop an entirely new approach,” said project leader John Goodacre. He’s an emeritus professor at Lancaster University, in the United Kingdom.

“Potentially, this could transform ways in which knee osteoarthritis is managed. It will enable better diagnosis, and will enable treatments to be tailored more precisely according to individual knee condition. It will also enable faster, bigger and better clinical trials of new treatments,” Goodacre said in a university news release.

The next step for researchers is to develop a non-invasive portable device that health care providers could use to assess whether patients’ knees are changing or are responding to treatment for osteoarthritis.

This technique could provide a quicker, cheaper, more convenient and more accurate assessment than current methods, the study authors said.

 

Remember!   We are in this together!

Health and Wellness Associates
EHS Telehealth

WordPress:  https://healthandwellnessassociates.co/

 

 

Health and Disease, Uncategorized

Newer Diabetes Drugs Linked to ‘Flesh-Eating’ Genital Infection

Newer Diabetes Drugs Linked to ‘Flesh-Eating’ Genital Infection

News Picture: Newer Diabetes Drugs Linked to 'Flesh-Eating' Genital Infection

Say you have type 2 diabetes and you are taking a newer class of medications to treat your disease — but one day you notice pain, redness and a foul odor in your genital area.

If this happens, new research suggests you need to see your doctor immediately, because you may be suffering from Fournier gangrene. Also known as a “flesh-eating” disease, this infection attacks your genital or anal region and can quickly kill tissue as it spreads rapidly.

Unfortunately, it has become a rare but still possible safety concern for people taking diabetes medications known as SGLT2 inhibitors, according to U.S. Food and Drug Administration scientists.

SGLT2 inhibitors are a newer class of diabetes medications, introduced in 2013. Drugs in this class include canagliflozin (Invokana), dapagliflozin (Farxiga) and empagliflozin (Jardiance).

Fournier gangrene occurred in 55 people taking these drugs between March 2013 and January 2019. For comparison, the researchers looked for cases of Fournier gangrene in people taking other diabetes medications from 1984 to 2019. They found only 19 such cases.

Still, the risk for Fournier gangrene remains very low, the researchers stressed.

“In 2017, an estimated 1.7 million patients received a dispensed prescription for an SGLT2 inhibitor,” said study author Dr. Susan Bersoff-Matcha, a medical officer in the FDA’s Center for Drug Evaluation and Research. So, “Fournier gangrene is a rare event,” she said. “While our study shows an association between treatment with SGLT2 inhibitors and Fournier gangrene, we don’t know exactly what the risk is, or if Fournier gangrene can be predicted.”

Broad-spectrum antibiotics and surgery to remove the dead tissue are treatment options, the researchers said.

SGLT2 inhibitors work in the kidneys, allowing excess blood sugar to be removed in the urine, they said.

In addition to lowering blood sugar levels, the drugs may also reduce the risk of heart disease and stroke in some people with type 2 diabetes.

But possible side effects include urinary tract infections and genital infections, such as yeast infections. Kidney problems can also be a concern with this class of medications.

All of the patients with Fournier gangrene identified in this study needed to be hospitalized. Some had several surgeries. Three of the 55 people died from Fournier gangrene.

The average age of the people with Fournier gangrene was 56. Thirty-nine were men. Forty-one cases occurred in the United States. Thirty-one of the 55 cases identified were also taking an additional diabetes medication.

Of those with Fournier gangrene, 21 were using canagliflozin, 16 were using dapagliflozin and 18 were taking empagliflozin, the study said.

Dr. Joel Zonszein, director of the clinical diabetes center at Montefiore Medical Center in New York City, said that while the study was well-done, it cannot prove a cause-and-effect link between the drugs and the disease.

“Infections of the pubic and rectal area are quite common in people with diabetes, they don’t have Fournier’s. Fournier’s is a very aggressive, but extremely rare, disease,” said Zonszein, who wasn’t involved with the study.

When Fournier gangrene does occur, it’s hard to know if it is caused by a medication. He pointed out that a number of clinical trials have been done on SGLT2 inhibitors that have included tens of thousands of people, and there haven’t been any reports of Fournier gangrene.

“I counsel my patients about infections in the genitalia. The main concern is to be aware that they can occur. And, providers need to be more aware of Fournier’s. They have to immediately try to establish the cause of infection and aggressively treat it if they suspect Fournier gangrene,” Zonszein said.

He said a far bigger concern is uncontrolled diabetes and the risk of complications when blood sugar levels aren’t controlled. “The benefits of these medications outweigh the risks,” he said.

In a statement, Boehringer Ingelheim, the company that makes Jardiance (empagliflozin), said the company actively monitors for side effects related to their medications.

“We remain confident in the positive benefit-risk profile of empagliflozin, and empagliflozin-containing products, as outlined in the prescribing information,” the statement from Boehringer Ingelheim said.

The prescribing information of all SGLT2’s was recently changed to reflect the possible risk of Fournier gangrene, as directed by the FDA.

Janssen Pharmaceuticals, maker of Invokana (canagliflozin), and AstraZeneca, maker of Farxiga (dapagliflozin), did not respond to requests for comment.

The findings were published May 6 2019 in the Annals of Internal Medicine.

 

We are in this together!

Health and Wellness Associates
EHS Telehealth

WordPress:  https://healthandwellnessassociates.co/

Health and Disease, Uncategorized

Sleep Apnea Linked to Diabetic Eye Disease

Sleep Apnea Linked to Diabetic Eye Disease

News Picture: Sleep Apnea Linked to Diabetic Eye Disease

Severe sleep apnea is a risk factor for diabetic eye disease that can lead to vision loss and blindness, researchers report.

Poor control of diabetes can result in damage to tiny blood vessels at the back of the eye, a condition called diabetic retinopathy. It’s a leading cause of blindness in the United States.

In some cases, tiny bulges protrude from the blood vessels and leak fluid and blood into the retina. This fluid can cause swelling (edema) in an area of the retina that enables clear vision and is called macular edema.

In this study, researchers in Taiwan examined data from 51 patients over eight years at Chang Gung Memorial Hospital in Taipei.

They found that patients with diabetic macular edema had a much higher rate (80.6%) of severe sleep apnea than those without the eye condition (45.5%).

The worse the sleep apnea, the more severe the macular edema, according to the study.

The researchers also found that severe sleep apnea was more common patients who required more treatment to control their macular edema. These patients needed at least three medical or laser therapy treatments, according to the study. It was to be presented Monday at the annual meeting of the American Academy of Ophthalmology (AAO), in San Francisco.

“Based on these results, we hope that more medical professionals will approach sleep apnea as a risk factor for diabetic macular edema,” lead researcher Dr. Juifan Chiang said in an AAO news release.

“This could allow for earlier medical intervention so patients can keep more of their vision and preserve their overall health as much as possible,” Chiang added.

People with sleep apnea repeatedly stop and start breathing through the night, disrupting their sleep and causing blood oxygen levels to fall.

This decline in blood oxygen levels may trigger changes in the body that result in blood vessel damage, putting people with sleep apnea at risk for high blood pressure, heart attack, stroke and type 2 diabetes.

Findings presented at scientific meetings are considered preliminary until published in a peer-reviewed journal.

 

We are in this together!

Health and Wellness Associates
EHS Telehealth

WordPress:  https://healthandwellnessassociates.co/